All
Small But Mighty: ROS1ers Unite
I have a rare mutation causing my cancer. Are there any others with ROS1 out there?
Phase 2 Study of Novel Vaccine Underway in Newly Diagnosed Glioblastoma
Patients with newly diagnosed glioblastoma are now being accepted at two institutions to enter a phase 2 study to assess the efficacy of the SurVaxM vaccine in combination with standard chemotherapy.
Living and Dying Might Depend on Cost
Which life is worth saving? More and more it depends on the cost of the drug used to treat your cancer.
Considering Weight Loss
The day came when I looked in the mirror and I didn't like what I saw. Here I was 5"7', and tipping the scales at 225 lbs.
A Recipe for Cancer Recovery
A male breast cancer survivor's menu for mending.
Adjuvant Avastin Does Not Improve Survival in NSCLC
The addition of Avastin (bevacizumab) to chemotherapy after initial therapy did not improve overall survival in patients with surgically resected early-stage non–small cell lung cancer.
April Hero Spotlight: Megan Pervier
My dad was diagnosed with Stage 4 lung cancer in February of 2014. His diagnosis included the BRAF mutation, which is still in the process of being researched for successful treatments.
Kim Statham Ringen on the Importance of Meeting Other Survivors
Kim Statham Ringen, DVM DACVIM (Oncology), a CURE contributor who is currently surviving stage 4 non-small cell lung cancer, discusses the importance of meeting other cancer survivors.
Scale Back: Honoring My Changed Body
It's hard to honor our bodies and respect what we need, especially when we are sick bodies living in a sea of the well.
Sleep Better Longer
Challenges to find healthy sleep come for a number of reasons, researchers are finding, including physical and psychological issues.
Researchers Distressed by Overregulation of Drug Development
Overregulation of new drug development has driven up the cost of care and resulted in significant loss of human life by delaying the approval of effective medications, according to David J. Stewart.
Actionable Mutations Common in Lung Cancer Patients Under 40
Most patients younger than age 40 with lung cancer had tumors with mutations that can be targeted with existing therapies, according to a preliminary analysis of data from an ongoing study.
180 Days From an Allogeneic Stem Cell Transplant
Returning to the mechanics of transplant, Kevin gives some details of the six-month milestone, but is unable to refrain from a bit of hopeful philosophy.
Share Hugs for Brady
Every year, thousands of children are diagnosed with cancer in the United States. Sherrie and Michael Wells started the Hugs for Brady Foundation to help end pediatric cancer for good.
Melanoma, Melanoma, Oh My Skin Woes and a New Option -Â For Some
Melanoma survivor vents about her "procedures" and discusses digital mole mapping.
Mouth Rinse Could Predict HPV-Related Oral Cancer Recurrence
Gypsyamber D'Souza and other researchers at the Johns Hopkins Bloomberg School of Public Health monitored 124 patients newly diagnosed with oropharyngeal cancer from 2009 through 2013.
Music Before Breast Surgery May Calm Nerves
Listening to music before undergoing ambulatory surgery for the diagnosis or treatment of breast cancer lessens patients' anxiety levels.
Debra Patt on the Challenges of Enrolling in the Health Insurance Marketplace
Debra Patt from Texas Oncology and The US Oncology Network discusses some challenges patients face when trying to enroll in the Health Insurance Marketplace.
Debra Patt Discusses the Impact of Health Care Reform on Patients
Debra Patt, from Texas Oncology and The US Oncology Network, discusses the impact of health care reform on patients with cancer.
Raising Awareness About Genetic Counseling and Testing
Like many advocates of a cause, Amy Byer Shainman's passion came from a place of frustration.
FDA Expands Emend's CINV Indication
The FDA has expanded the approval of Emend's indication for chemotherapy-induced nausea and vomiting.
Susan Krigel on the Effect of Fear of Recurrence on Quality of Life
Susan Krigel, from the Midwest Cancer Alliance, discusses the effect of fear of recurrence on a cancer survivor's quality of life.
Susan Krigel Discusses Fear of Recurrence Among Cancer Survivors
Susan Krigel, from the Midwest Cancer Alliance, discusses fear of recurrence among cancer survivors.
FDA Approves Varubi for CINV
The FDA has approved Varubi for use in combination with other antiemetic agents to prevent delayed chemotherapy-induced nausea and vomiting from initial and repeat chemotherapy regimens, including highly emetogenic chemotherapy.
What Do 120 Cancer Survivors Have in Common?
Photographer and cancer survivor chronicles journeys of affirmation — including his own.
The Julie Fund for Women's Cancers Charges into its Second Decade
Ten years after founding The Julie Fund for Women's Cancers, President Peter McAvinn's resolve is stronger than ever.
Inspiring Resilience
One thing cancer survivors seem to have in common is a capacity for resilience and an ability to take the challenges a cancer diagnosis brings and channel them into something positive.
Getting Some Sleep: New Strategies for Survivors
Sleep disorders are finally getting the attention they deserve.
Caffeinated Coffee May Reduce Risk of Colon Cancer Recurrence
Does drinking a lot of coffee reduce colon cancer recurrence risk? Possibly.
Living With Stage 4 Breast Cancer: My Semi-Charmed Kind of Life
I led a fairly charmed life up until about the age of 29. Life just always seemed to work out for me. I was the gal who had a flat tire 100 yards from the tire shop.
